Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Pharmaceuticals Corporation Announces Second Quarter 2008 Operating Results Aug 14, 2008 ... Read more Summary ToggleTekmira Pharmaceuticals Announces RNAi Research Collaboration with Bristol-Myers Squibb Aug 13, 2008 Tekmira Pharmaceuticals Announces RNAi Research Collaboration with Bristol-Myers Squibb 16.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory Aug 11, 2008 Tekmira Pharmaceuticals Conference Call Advisory 12.2 KB 2008 Quarter Operating Results ... Read more Summary ToggleTekmira Pharmaceuticals Provides Progress Update on Alnylam Collaboration Aug 06, 2008 Tekmira Pharmaceuticals Provides Progress Update on Alnylam Collaboration 17 KB ... Read more Summary ToggleTekmira Pharmaceuticals Selects Two Products for Clinical Development in 2009 Jul 21, 2008 Tekmira Pharmaceuticals Selects Two Products for Clinical Development in 2009 18.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination Jun 01, 2008 Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination 18.5 KB $10.0 Million Private Placement with Alnylam Pharmaceuticals and Roche Completed ... Read more Summary ToggleShareholders of Tekmira Pharmaceuticals Approve Business Combination with Protiva Biotherapeutics May 28, 2008 Shareholders of Tekmira Pharmaceuticals Approve Business Combination with Protiva Biotherapeutics 16 KB ... Read more Summary ToggleTekmira Pharmaceuticals Announces an Amendment to its Share Option Plan May 15, 2008 Tekmira Pharmaceuticals Announces an Amendment to its Share Option Plan 12.7 KB RiskMetrics Recommends that Shareholders Vote in Favour of the Business Combination with Protiva ... Read more Summary ToggleTekmira Pharmaceuticals Corporation Releases First Quarter 2008 Operating Results May 14, 2008 Tekmira Pharmaceuticals Corporation Releases First Quarter 2008 Operating Results 21.4 KB ... Read more Summary ToggleTekmira Pharmaceuticals Appoints Dr. Arthur M. Bruskin to Board of Directors May 06, 2008 ... Read more Pagination First page First Previous page Previous … Page 50 Current page 51 Page 52 Page 53 Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Pharmaceuticals Corporation Announces Second Quarter 2008 Operating Results Aug 14, 2008 ... Read more Summary ToggleTekmira Pharmaceuticals Announces RNAi Research Collaboration with Bristol-Myers Squibb Aug 13, 2008 Tekmira Pharmaceuticals Announces RNAi Research Collaboration with Bristol-Myers Squibb 16.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory Aug 11, 2008 Tekmira Pharmaceuticals Conference Call Advisory 12.2 KB 2008 Quarter Operating Results ... Read more Summary ToggleTekmira Pharmaceuticals Provides Progress Update on Alnylam Collaboration Aug 06, 2008 Tekmira Pharmaceuticals Provides Progress Update on Alnylam Collaboration 17 KB ... Read more Summary ToggleTekmira Pharmaceuticals Selects Two Products for Clinical Development in 2009 Jul 21, 2008 Tekmira Pharmaceuticals Selects Two Products for Clinical Development in 2009 18.1 KB ... Read more Summary ToggleTekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination Jun 01, 2008 Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination 18.5 KB $10.0 Million Private Placement with Alnylam Pharmaceuticals and Roche Completed ... Read more Summary ToggleShareholders of Tekmira Pharmaceuticals Approve Business Combination with Protiva Biotherapeutics May 28, 2008 Shareholders of Tekmira Pharmaceuticals Approve Business Combination with Protiva Biotherapeutics 16 KB ... Read more Summary ToggleTekmira Pharmaceuticals Announces an Amendment to its Share Option Plan May 15, 2008 Tekmira Pharmaceuticals Announces an Amendment to its Share Option Plan 12.7 KB RiskMetrics Recommends that Shareholders Vote in Favour of the Business Combination with Protiva ... Read more Summary ToggleTekmira Pharmaceuticals Corporation Releases First Quarter 2008 Operating Results May 14, 2008 Tekmira Pharmaceuticals Corporation Releases First Quarter 2008 Operating Results 21.4 KB ... Read more Summary ToggleTekmira Pharmaceuticals Appoints Dr. Arthur M. Bruskin to Board of Directors May 06, 2008 ... Read more Pagination First page First Previous page Previous … Page 50 Current page 51 Page 52 Page 53 Next page Next Last page Last
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination 18.5 KB
Shareholders of Tekmira Pharmaceuticals Approve Business Combination with Protiva Biotherapeutics 16 KB
